| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 96 | 2024 | 2370 | 12.440 |
Why?
|
| Radiotherapy, Intensity-Modulated | 60 | 2024 | 2104 | 8.980 |
Why?
|
| Image Processing, Computer-Assisted | 40 | 2023 | 1648 | 7.060 |
Why?
|
| Tomography, X-Ray Computed | 78 | 2024 | 7551 | 6.630 |
Why?
|
| Radiotherapy Dosage | 66 | 2024 | 3842 | 4.080 |
Why?
|
| Radiotherapy, Conformal | 17 | 2023 | 902 | 4.070 |
Why?
|
| Head and Neck Neoplasms | 36 | 2023 | 3976 | 3.990 |
Why?
|
| Organs at Risk | 27 | 2024 | 514 | 3.720 |
Why?
|
| Radiotherapy, Image-Guided | 15 | 2019 | 304 | 3.520 |
Why?
|
| Phantoms, Imaging | 33 | 2023 | 1271 | 3.340 |
Why?
|
| Particle Accelerators | 11 | 2021 | 352 | 3.190 |
Why?
|
| Uterine Cervical Neoplasms | 12 | 2024 | 1833 | 2.900 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 31 | 2023 | 5319 | 2.680 |
Why?
|
| Algorithms | 38 | 2023 | 3890 | 2.400 |
Why?
|
| Esophagitis | 5 | 2017 | 202 | 2.390 |
Why?
|
| Radiometry | 22 | 2022 | 980 | 2.390 |
Why?
|
| Patient Positioning | 5 | 2019 | 195 | 2.360 |
Why?
|
| Esophagus | 8 | 2023 | 553 | 2.230 |
Why?
|
| Automation | 12 | 2023 | 151 | 2.070 |
Why?
|
| Lung Neoplasms | 36 | 2023 | 11538 | 2.030 |
Why?
|
| Radiation Injuries | 12 | 2020 | 1411 | 2.000 |
Why?
|
| Cone-Beam Computed Tomography | 6 | 2018 | 202 | 1.820 |
Why?
|
| Immobilization | 5 | 2017 | 93 | 1.640 |
Why?
|
| Motion | 9 | 2018 | 193 | 1.630 |
Why?
|
| Software | 14 | 2023 | 1321 | 1.610 |
Why?
|
| Four-Dimensional Computed Tomography | 11 | 2023 | 226 | 1.580 |
Why?
|
| Healthcare Failure Mode and Effect Analysis | 2 | 2022 | 8 | 1.550 |
Why?
|
| Positron-Emission Tomography | 11 | 2023 | 2173 | 1.520 |
Why?
|
| Radiotherapy Setup Errors | 4 | 2019 | 80 | 1.470 |
Why?
|
| Artifacts | 9 | 2021 | 532 | 1.470 |
Why?
|
| Humans | 185 | 2024 | 261506 | 1.410 |
Why?
|
| Radiation Dosage | 16 | 2020 | 1014 | 1.400 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 7 | 2016 | 361 | 1.390 |
Why?
|
| Lung | 10 | 2020 | 3151 | 1.340 |
Why?
|
| Neck | 5 | 2023 | 383 | 1.330 |
Why?
|
| Thorax | 3 | 2018 | 213 | 1.320 |
Why?
|
| Reproducibility of Results | 36 | 2023 | 6009 | 1.290 |
Why?
|
| Cooperative Behavior | 2 | 2024 | 313 | 1.280 |
Why?
|
| Cerebellar Neoplasms | 2 | 2023 | 434 | 1.280 |
Why?
|
| Medulloblastoma | 2 | 2023 | 540 | 1.230 |
Why?
|
| Monte Carlo Method | 9 | 2020 | 671 | 1.180 |
Why?
|
| Radiation Oncology | 6 | 2023 | 529 | 1.170 |
Why?
|
| Respiration | 9 | 2019 | 447 | 1.080 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2019 | 1226 | 1.070 |
Why?
|
| Artificial Intelligence | 10 | 2024 | 388 | 1.050 |
Why?
|
| Mastectomy | 3 | 2024 | 1534 | 1.040 |
Why?
|
| Oropharyngeal Neoplasms | 5 | 2018 | 1105 | 1.030 |
Why?
|
| Models, Biological | 8 | 2018 | 3254 | 0.990 |
Why?
|
| International Cooperation | 2 | 2024 | 323 | 0.980 |
Why?
|
| Endoscopy | 2 | 2017 | 479 | 0.940 |
Why?
|
| Quality Assurance, Health Care | 7 | 2019 | 585 | 0.910 |
Why?
|
| Retrospective Studies | 39 | 2024 | 37905 | 0.870 |
Why?
|
| Thoracic Neoplasms | 3 | 2019 | 337 | 0.860 |
Why?
|
| Radiography, Thoracic | 4 | 2019 | 462 | 0.850 |
Why?
|
| Radiotherapy, Computer-Assisted | 3 | 2019 | 126 | 0.840 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 592 | 0.810 |
Why?
|
| Tumor Burden | 9 | 2019 | 1987 | 0.800 |
Why?
|
| Prostatic Neoplasms | 13 | 2023 | 5767 | 0.790 |
Why?
|
| Craniospinal Irradiation | 1 | 2023 | 128 | 0.790 |
Why?
|
| Quality Control | 3 | 2019 | 457 | 0.760 |
Why?
|
| Computer Simulation | 16 | 2024 | 1529 | 0.740 |
Why?
|
| Head | 5 | 2021 | 249 | 0.730 |
Why?
|
| Models, Theoretical | 3 | 2019 | 785 | 0.730 |
Why?
|
| Neoplasms | 13 | 2023 | 15193 | 0.720 |
Why?
|
| Radiotherapy | 4 | 2018 | 1824 | 0.710 |
Why?
|
| Radiopharmaceuticals | 6 | 2019 | 1301 | 0.710 |
Why?
|
| Heart | 7 | 2023 | 1223 | 0.690 |
Why?
|
| Prostate | 5 | 2023 | 1088 | 0.680 |
Why?
|
| Proton Therapy | 7 | 2023 | 1577 | 0.680 |
Why?
|
| Tomography, Spiral Computed | 2 | 2013 | 133 | 0.670 |
Why?
|
| Radiographic Image Enhancement | 4 | 2015 | 402 | 0.660 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2018 | 82 | 0.650 |
Why?
|
| Movement | 8 | 2019 | 556 | 0.640 |
Why?
|
| Electricity | 1 | 2018 | 17 | 0.640 |
Why?
|
| Biomarkers | 4 | 2021 | 5047 | 0.630 |
Why?
|
| Tomography Scanners, X-Ray Computed | 5 | 2019 | 88 | 0.620 |
Why?
|
| Thoracic Wall | 1 | 2020 | 183 | 0.620 |
Why?
|
| Rectal Neoplasms | 2 | 2024 | 1202 | 0.610 |
Why?
|
| Developing Countries | 1 | 2019 | 315 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2023 | 7702 | 0.580 |
Why?
|
| Female | 51 | 2024 | 141928 | 0.570 |
Why?
|
| Sensitivity and Specificity | 16 | 2016 | 4971 | 0.570 |
Why?
|
| Multimodal Imaging | 2 | 2023 | 550 | 0.570 |
Why?
|
| Internet | 4 | 2023 | 706 | 0.550 |
Why?
|
| Posture | 2 | 2014 | 215 | 0.530 |
Why?
|
| Magnetic Fields | 1 | 2015 | 31 | 0.530 |
Why?
|
| Organ Sparing Treatments | 2 | 2017 | 277 | 0.530 |
Why?
|
| Observer Variation | 9 | 2020 | 671 | 0.530 |
Why?
|
| Breast Neoplasms | 5 | 2024 | 15694 | 0.520 |
Why?
|
| Radiation Tolerance | 3 | 2017 | 629 | 0.520 |
Why?
|
| Rectum | 7 | 2024 | 467 | 0.510 |
Why?
|
| Calibration | 5 | 2018 | 337 | 0.500 |
Why?
|
| Feasibility Studies | 8 | 2023 | 2292 | 0.480 |
Why?
|
| Computed Tomography Angiography | 1 | 2015 | 234 | 0.470 |
Why?
|
| Male | 49 | 2024 | 123000 | 0.470 |
Why?
|
| Lymph Nodes | 3 | 2022 | 2967 | 0.460 |
Why?
|
| Skin | 2 | 2010 | 1259 | 0.450 |
Why?
|
| Aged | 33 | 2021 | 70117 | 0.450 |
Why?
|
| Uncertainty | 5 | 2018 | 320 | 0.420 |
Why?
|
| Contrast Media | 2 | 2015 | 1472 | 0.410 |
Why?
|
| Breast | 2 | 2018 | 1344 | 0.410 |
Why?
|
| Aged, 80 and over | 19 | 2021 | 29902 | 0.410 |
Why?
|
| Middle Aged | 33 | 2021 | 86204 | 0.390 |
Why?
|
| Skin Physiological Phenomena | 2 | 2008 | 43 | 0.390 |
Why?
|
| Subtraction Technique | 3 | 2015 | 141 | 0.390 |
Why?
|
| Benchmarking | 3 | 2021 | 273 | 0.370 |
Why?
|
| Workflow | 4 | 2021 | 275 | 0.370 |
Why?
|
| Protons | 1 | 2013 | 473 | 0.370 |
Why?
|
| Health Physics | 2 | 2020 | 63 | 0.350 |
Why?
|
| Carbon | 1 | 2010 | 149 | 0.350 |
Why?
|
| Dental Restoration, Permanent | 1 | 2009 | 5 | 0.350 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 121 | 0.340 |
Why?
|
| Mesothelioma | 3 | 2009 | 544 | 0.340 |
Why?
|
| Adult | 22 | 2023 | 77950 | 0.330 |
Why?
|
| Respiratory Mechanics | 3 | 2014 | 173 | 0.330 |
Why?
|
| Photons | 4 | 2021 | 507 | 0.320 |
Why?
|
| Pelvis | 2 | 2022 | 362 | 0.320 |
Why?
|
| Parotid Gland | 3 | 2023 | 112 | 0.320 |
Why?
|
| Medical Errors | 1 | 2010 | 219 | 0.320 |
Why?
|
| Prognosis | 11 | 2019 | 21713 | 0.320 |
Why?
|
| Respiratory-Gated Imaging Techniques | 3 | 2019 | 51 | 0.310 |
Why?
|
| ROC Curve | 4 | 2020 | 1183 | 0.310 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2017 | 925 | 0.300 |
Why?
|
| Optically Stimulated Luminescence Dosimetry | 2 | 2018 | 16 | 0.300 |
Why?
|
| Radiosurgery | 3 | 2019 | 1330 | 0.290 |
Why?
|
| Neoplasm Staging | 8 | 2019 | 13658 | 0.280 |
Why?
|
| Intra-Abdominal Fat | 2 | 2017 | 95 | 0.270 |
Why?
|
| Linear Models | 4 | 2021 | 1085 | 0.260 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2023 | 833 | 0.260 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 329 | 0.260 |
Why?
|
| Seminal Vesicles | 1 | 2005 | 152 | 0.260 |
Why?
|
| Pattern Recognition, Automated | 2 | 2015 | 125 | 0.250 |
Why?
|
| Brain | 5 | 2022 | 4113 | 0.250 |
Why?
|
| Brain Stem | 2 | 2023 | 175 | 0.240 |
Why?
|
| Cancer Survivors | 2 | 2021 | 650 | 0.240 |
Why?
|
| Spine | 2 | 2022 | 293 | 0.240 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2006 | 285 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2018 | 5437 | 0.220 |
Why?
|
| Dose-Response Relationship, Radiation | 5 | 2017 | 726 | 0.220 |
Why?
|
| Mice | 7 | 2018 | 34495 | 0.220 |
Why?
|
| Knowledge Bases | 1 | 2022 | 41 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 543 | 0.210 |
Why?
|
| Induction Chemotherapy | 2 | 2016 | 669 | 0.210 |
Why?
|
| Mechanical Phenomena | 2 | 2019 | 30 | 0.200 |
Why?
|
| Radiation Pneumonitis | 2 | 2018 | 301 | 0.200 |
Why?
|
| Patient Care Planning | 2 | 2022 | 297 | 0.200 |
Why?
|
| Cloud Computing | 1 | 2021 | 16 | 0.200 |
Why?
|
| Chemoradiotherapy | 4 | 2023 | 1946 | 0.200 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2023 | 323 | 0.190 |
Why?
|
| Nanotechnology | 2 | 2018 | 137 | 0.190 |
Why?
|
| Peer Review | 1 | 2021 | 80 | 0.190 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 4988 | 0.180 |
Why?
|
| Pharynx | 1 | 2020 | 153 | 0.180 |
Why?
|
| Prospective Studies | 6 | 2023 | 12873 | 0.180 |
Why?
|
| Models, Statistical | 4 | 2018 | 1171 | 0.180 |
Why?
|
| Brachytherapy | 2 | 2018 | 977 | 0.180 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 118 | 0.170 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 245 | 0.170 |
Why?
|
| Anus Neoplasms | 1 | 2023 | 411 | 0.170 |
Why?
|
| Breath Holding | 1 | 2019 | 44 | 0.170 |
Why?
|
| Electromagnetic Fields | 1 | 2018 | 50 | 0.170 |
Why?
|
| Poverty | 2 | 2022 | 471 | 0.170 |
Why?
|
| Computational Biology | 2 | 2023 | 1271 | 0.170 |
Why?
|
| Evaluation Studies as Topic | 1 | 2019 | 418 | 0.170 |
Why?
|
| Tongue Neoplasms | 2 | 2014 | 246 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 589 | 0.160 |
Why?
|
| Water | 2 | 2019 | 361 | 0.160 |
Why?
|
| Area Under Curve | 2 | 2019 | 700 | 0.160 |
Why?
|
| Clusterin | 1 | 2017 | 28 | 0.160 |
Why?
|
| Analysis of Variance | 2 | 2017 | 2307 | 0.160 |
Why?
|
| Statistics, Nonparametric | 2 | 2017 | 980 | 0.150 |
Why?
|
| Obesity, Abdominal | 1 | 2017 | 43 | 0.150 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 117 | 0.150 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 295 | 0.150 |
Why?
|
| Relative Biological Effectiveness | 2 | 2008 | 219 | 0.150 |
Why?
|
| Time Factors | 4 | 2020 | 12926 | 0.150 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 92 | 0.140 |
Why?
|
| Rubber | 1 | 2015 | 6 | 0.140 |
Why?
|
| Plant Structures | 1 | 2015 | 8 | 0.140 |
Why?
|
| Radiography | 3 | 2013 | 1904 | 0.140 |
Why?
|
| Equipment Design | 4 | 2018 | 1204 | 0.130 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 2 | 2015 | 259 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 383 | 0.130 |
Why?
|
| Cranial Irradiation | 1 | 2017 | 315 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2021 | 732 | 0.130 |
Why?
|
| Mediastinal Neoplasms | 1 | 2019 | 423 | 0.130 |
Why?
|
| Preoperative Period | 1 | 2016 | 344 | 0.130 |
Why?
|
| Young Adult | 4 | 2023 | 21445 | 0.130 |
Why?
|
| Radiation Equipment and Supplies | 1 | 2014 | 4 | 0.130 |
Why?
|
| Polyethylene | 1 | 2014 | 19 | 0.120 |
Why?
|
| Animals | 8 | 2018 | 59536 | 0.120 |
Why?
|
| Exhalation | 1 | 2014 | 60 | 0.120 |
Why?
|
| Child | 4 | 2023 | 29154 | 0.120 |
Why?
|
| Models, Organizational | 1 | 2015 | 76 | 0.120 |
Why?
|
| Karnofsky Performance Status | 1 | 2014 | 175 | 0.120 |
Why?
|
| Urinary Bladder | 3 | 2023 | 575 | 0.120 |
Why?
|
| Lung Volume Measurements | 1 | 2014 | 88 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 1323 | 0.120 |
Why?
|
| Rotation | 1 | 2014 | 112 | 0.120 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 1162 | 0.120 |
Why?
|
| Time | 1 | 2014 | 178 | 0.120 |
Why?
|
| Software Design | 1 | 2013 | 40 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 690 | 0.120 |
Why?
|
| Spinal Neoplasms | 1 | 2019 | 631 | 0.120 |
Why?
|
| Printing, Three-Dimensional | 1 | 2015 | 129 | 0.120 |
Why?
|
| Probability | 1 | 2015 | 866 | 0.120 |
Why?
|
| Tonsillar Neoplasms | 1 | 2014 | 80 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2015 | 305 | 0.120 |
Why?
|
| Machine Learning | 3 | 2023 | 319 | 0.120 |
Why?
|
| Thyroid Neoplasms | 2 | 2015 | 1866 | 0.120 |
Why?
|
| Video Recording | 1 | 2015 | 267 | 0.120 |
Why?
|
| Supine Position | 1 | 2013 | 46 | 0.120 |
Why?
|
| Reference Values | 1 | 2015 | 1099 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 14889 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 3719 | 0.110 |
Why?
|
| Swine | 1 | 2017 | 1541 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 945 | 0.110 |
Why?
|
| Carbon Isotopes | 1 | 2014 | 333 | 0.110 |
Why?
|
| Adenocarcinoma | 3 | 2016 | 7789 | 0.110 |
Why?
|
| Logistic Models | 2 | 2020 | 3441 | 0.110 |
Why?
|
| Pyruvic Acid | 1 | 2014 | 133 | 0.110 |
Why?
|
| Esophageal Neoplasms | 2 | 2016 | 3168 | 0.110 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 1742 | 0.110 |
Why?
|
| Medical Informatics | 1 | 2015 | 198 | 0.110 |
Why?
|
| Palliative Care | 1 | 2023 | 2037 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2015 | 272 | 0.100 |
Why?
|
| Diaphragm | 1 | 2013 | 181 | 0.100 |
Why?
|
| Shoulder | 1 | 2012 | 62 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2015 | 2803 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 694 | 0.100 |
Why?
|
| Lymphoma | 1 | 2019 | 1467 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2014 | 6869 | 0.090 |
Why?
|
| Disease Progression | 3 | 2019 | 6682 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 669 | 0.090 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 1429 | 0.090 |
Why?
|
| Software Validation | 1 | 2010 | 32 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2014 | 518 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 1303 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2017 | 1154 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2021 | 32848 | 0.090 |
Why?
|
| Dental Materials | 1 | 2009 | 7 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2403 | 0.090 |
Why?
|
| Dental Amalgam | 1 | 2009 | 8 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2023 | 16273 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 10035 | 0.080 |
Why?
|
| Deoxycytidine | 1 | 2014 | 1353 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 987 | 0.080 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 4849 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 1299 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 10331 | 0.080 |
Why?
|
| Computers | 1 | 2008 | 141 | 0.080 |
Why?
|
| X-Rays | 1 | 2008 | 146 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2010 | 598 | 0.080 |
Why?
|
| Genomics | 1 | 2019 | 2738 | 0.080 |
Why?
|
| Transistors, Electronic | 1 | 2007 | 7 | 0.080 |
Why?
|
| Technology, Radiologic | 1 | 2007 | 80 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2015 | 806 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6207 | 0.070 |
Why?
|
| Larynx | 1 | 2008 | 134 | 0.070 |
Why?
|
| Adolescent | 3 | 2023 | 31252 | 0.070 |
Why?
|
| Online Systems | 1 | 2006 | 27 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 2594 | 0.070 |
Why?
|
| Body Size | 1 | 2006 | 70 | 0.070 |
Why?
|
| Feedback | 1 | 2006 | 198 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 5539 | 0.060 |
Why?
|
| Radiation Protection | 1 | 2005 | 205 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 410 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2008 | 447 | 0.060 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 187 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.060 |
Why?
|
| Peritoneal Cavity | 1 | 2023 | 56 | 0.060 |
Why?
|
| Cobalt Radioisotopes | 1 | 2023 | 42 | 0.060 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 140 | 0.060 |
Why?
|
| Systems Integration | 1 | 2003 | 76 | 0.060 |
Why?
|
| Cobalt | 1 | 2023 | 55 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 5687 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 470 | 0.060 |
Why?
|
| Academies and Institutes | 1 | 2023 | 95 | 0.060 |
Why?
|
| Obesity | 1 | 2015 | 2884 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2015 | 7226 | 0.050 |
Why?
|
| Tanzania | 1 | 2022 | 68 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2023 | 660 | 0.050 |
Why?
|
| Checklist | 1 | 2022 | 122 | 0.050 |
Why?
|
| Income | 1 | 2022 | 222 | 0.050 |
Why?
|
| Zambia | 1 | 2020 | 26 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 101 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 332 | 0.050 |
Why?
|
| Radiobiology | 1 | 2020 | 56 | 0.050 |
Why?
|
| Tomography | 1 | 2020 | 55 | 0.050 |
Why?
|
| Technology | 1 | 2021 | 96 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 1945 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2021 | 233 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 4638 | 0.040 |
Why?
|
| Lasers | 1 | 2019 | 198 | 0.040 |
Why?
|
| Risk Factors | 2 | 2013 | 17523 | 0.040 |
Why?
|
| Mediastinum | 1 | 2019 | 268 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5061 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2018 | 314 | 0.040 |
Why?
|
| Masks | 1 | 2017 | 57 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 187 | 0.040 |
Why?
|
| Necrosis | 1 | 2017 | 580 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 519 | 0.030 |
Why?
|
| Osteocytes | 1 | 2015 | 27 | 0.030 |
Why?
|
| Survivors | 1 | 2021 | 1031 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 14551 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 78 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 860 | 0.030 |
Why?
|
| Fiducial Markers | 1 | 2015 | 96 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 238 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 1053 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 1391 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 73 | 0.030 |
Why?
|
| Programming Languages | 1 | 2013 | 23 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 1972 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 314 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2014 | 210 | 0.030 |
Why?
|
| Netherlands | 1 | 2013 | 83 | 0.030 |
Why?
|
| Colon, Sigmoid | 1 | 2013 | 42 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 626 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 573 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2014 | 209 | 0.030 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2016 | 565 | 0.030 |
Why?
|
| Adipocytes | 1 | 2015 | 305 | 0.030 |
Why?
|
| Radiation Monitoring | 1 | 2013 | 49 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 181 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 597 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 875 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2018 | 1234 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 2961 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 717 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1516 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 584 | 0.030 |
Why?
|
| Pneumonectomy | 2 | 2007 | 831 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 733 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 482 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 624 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2010 | 66 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2014 | 652 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2017 | 851 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2014 | 636 | 0.020 |
Why?
|
| Consensus | 1 | 2014 | 978 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2013 | 690 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 1910 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4892 | 0.020 |
Why?
|
| Eye | 1 | 2010 | 301 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 1258 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2010 | 355 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 4298 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4744 | 0.020 |
Why?
|
| Mammography | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Heart Rate | 1 | 2010 | 737 | 0.020 |
Why?
|
| DNA Damage | 1 | 2015 | 1954 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5112 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 3033 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5159 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 316 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 699 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 2218 | 0.020 |
Why?
|
| Pemetrexed | 1 | 2006 | 102 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 9180 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 4307 | 0.020 |
Why?
|
| Glutamates | 1 | 2006 | 130 | 0.020 |
Why?
|
| Guanine | 1 | 2006 | 151 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 6311 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 13310 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 9244 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 4078 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 10001 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 2864 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3552 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12221 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 330 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 2231 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 627 | 0.010 |
Why?
|
| Cisplatin | 1 | 2006 | 2432 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 15179 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 3890 | 0.010 |
Why?
|
| United States | 1 | 2014 | 15433 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 14289 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 15862 | 0.000 |
Why?
|